Immunoelectron microscopic application of monoclonal antibodies for identification of lymphocyte subsets bearing tubuloreticular inclusions or parallel tubular arrays.

Important note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.

Immunoelectron microscopic application of monoclonal antibodies for identification of lymphocyte subsets bearing tubuloreticular inclusions or parallel tubular arrays.

J Exp Pathol. 1984;1(2):157-73. Unique Identifier : AIDSLINE MED/88117834
Kang YH; Yaffe L; Grimley PM; Department of Pathology, Uniformed Services University of the; Health Sciences, Bethesda, MD.

Abstract: Reactions of mouse monoclonal antibodies with T-cell, B-cell, or NK cell antigens were localized for electron microscopy by the formation of avidin-biotin-peroxidase complexes using direct or indirect labeling techniques. The techniques proved advantageous for identification of lymphocyte subsets bearing two different types of cytoplasmic structures: tubuloreticular inclusions (TRI) which have been related to interferon treatment or to diseases involving systemic immune dysfunctions, and parallel tubular arrays (PTA) which may be normal structures. Mononuclear cell samples were isolated from the peripheral blood of patients with systematic lupus erythematosus (SLE), acquired immunodeficiency syndrome (AIDS), or chronic hepatitis B (CHB). Results depended upon the fixation, the type of specific antibody, and the concentrations employed. Brief fixation in 1% glutaraldehyde/1% paraformaldehyde proved useful for stable preservation of both the inclusion fine structure and surface antigen activity, even after prolonged storage in buffer. The T-cell subset antigens (Leu-2a and Leu-3a) were more labile than the pan-T-cell antigen (Leu-1), the B-cell surface antigen (Leu-10), or the NK cell antigen (Leu-7). Localization of the former was improved by a two-step labeling procedure with primary and secondary antibodies. Both TRI and PTA were identified in T cells. Either type of inclusion could be found in the suppressor/cytotoxic or helper/inducer T-cell subsets. TRI also were found in a few anti-Leu-10 reactive cells. A crystalline form of PTA was identified in anti-Leu-1 and anti-Leu-7 reactive cells.

Keywords: Acquired Immunodeficiency Syndrome/BLOOD *Antibodies, Monoclonal Antigens, Differentiation, T-Lymphocyte/ANALYSIS Antigens, Surface/ANALYSIS B-Lymphocytes/IMMUNOLOGY/ULTRASTRUCTURE Cytoplasm/*ULTRASTRUCTURE Hepatitis B/BLOOD Human Immunoenzyme Techniques Inclusion Bodies/*ULTRASTRUCTURE Killer Cells, Natural/IMMUNOLOGY/ULTRASTRUCTURE Lupus Erythematosus, Systemic/BLOOD Lymphocytes/IMMUNOLOGY/*ULTRASTRUCTURE Microscopy, Electron Support, Non-U.S. Gov't Support, U.S. Gov't, Non-P.H.S. T-Lymphocytes/IMMUNOLOGY/ULTRASTRUCTURE JOURNAL ARTICLE

880530
M8850465

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .